BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3569864)

  • 1. HLA haplotype sharing and proband genotype in IDDM.
    Rotter JI; Vadheim CM; Petersen GM; Cantor RM; Riley WJ; Maclaren NK
    Genet Epidemiol Suppl; 1986; 1():347-52. PubMed ID: 3569864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR effects in a large German IDDM dataset.
    Field LL; Fothergill-Payne C; Bertrams J; Baur MP
    Genet Epidemiol Suppl; 1986; 1():323-8. PubMed ID: 3471665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA haplotype sharing in IDDM affected sib pairs as a function of HLA DR genotype.
    Falk CT
    Genet Epidemiol Suppl; 1986; 1():353-8. PubMed ID: 3471668
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes.
    Deschamps I; Marcelli-Barge A; Lallemand N; Poirier JC; Bochu V; Prévost P; Busson A; Massét M; Lestradet H; Hors J
    Tissue Antigens; 1988 May; 31(5):259-69. PubMed ID: 3400091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.
    Horn GT; Bugawan TL; Long CM; Manos MM; Erlich HA
    Hum Immunol; 1988 Apr; 21(4):249-63. PubMed ID: 3372263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family analysis for IDDM--HLA. Comparison of the two-allele model versus the three-allele model.
    Neugebauer M; Bertrams J; Baur MP
    Genet Epidemiol Suppl; 1986; 1():335-40. PubMed ID: 3471667
    [No Abstract]   [Full Text] [Related]  

  • 7. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
    Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
    Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
    Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
    J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
    Fennessy M; Metcalfe K; Hitman GA; Niven M; Biro PA; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
    Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic heterogeneity of insulin-dependent (type I) diabetes mellitus: evidence from a study of extended haplotypes.
    Rich SS; Weitkamp LR; Barbosa J
    Am J Hum Genet; 1984 Sep; 36(5):1015-23. PubMed ID: 6594040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus.
    Thomson G; Robinson WP; Kuhner MK; Joe S; MacDonald MJ; Gottschall JL; Barbosa J; Rich SS; Bertrams J; Baur MP
    Am J Hum Genet; 1988 Dec; 43(6):799-816. PubMed ID: 3057885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Gm haplotype study in relation with HLA-DR in 155 insulin-dependent diabetic patients and their affected and non affected siblings.
    Deschamps I; Blanc M; Dizier MH; Lestradet H; Hors J
    Exp Clin Endocrinol; 1987 Aug; 89(3):325-32. PubMed ID: 3666050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell defined HLA epitopes and T cell receptor polymorphism in insulin dependent diabetes mellitus.
    Sheehy MJ
    Baillieres Clin Endocrinol Metab; 1991 Jun; 5(2):341-55. PubMed ID: 1716435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different HLA haplotypes in Mexican Americans with IDDM.
    Vadheim CM; Zeidler A; Rotter JI; Langbaum M; Shulman IA; Spencer MR; Costin G; Riley WJ; Maclaren NK
    Diabetes Care; 1989; 12(7):497-500. PubMed ID: 2758954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential transmission of diabetic alleles within the HLA gene complex.
    Vadheim CM; Rotter JI; Maclaren NK; Riley WJ; Anderson CE
    N Engl J Med; 1986 Nov; 315(21):1314-8. PubMed ID: 3490623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong association of HLA-DR3/DRw9 heterozygosity with early-onset insulin-dependent diabetes mellitus in Chinese.
    Hawkins BR; Lam KS; Ma JT; Low LC; Cheung PT; Serjeantson SW; Yeung RT
    Diabetes; 1987 Nov; 36(11):1297-300. PubMed ID: 3499357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population.
    Huang HS; Peng JT; She JY; Zhang LP; Chao CC; Liu KH; She JX
    Hum Immunol; 1995 Dec; 44(4):210-9. PubMed ID: 8770634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors in insulin-dependent diabetes].
    Deschamps I; Lestradet H; Marcelli-Barge A; Poirier JC; Cohen D; Hors J
    Pathol Biol (Paris); 1986 Jun; 34(6):767-72. PubMed ID: 3531993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.